Literature DB >> 27488681

Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.

Jonine D Figueroa1,2, Ruth M Pfeiffer3, Louise A Brinton3, Maya M Palakal3, Amy C Degnim4, Derek Radisky4, Lynn C Hartmann4, Marlene H Frost4, Melody L Stallings Mann4, Daphne Papathomas3, Gretchen L Gierach3, Stephen M Hewitt5, Maire A Duggan6, Daniel Visscher4, Mark E Sherman7.   

Abstract

Lesser degrees of terminal duct-lobular unit (TDLU) involution predict higher breast cancer risk; however, standardized measures to quantitate levels of TDLU involution have only recently been developed. We assessed whether three standardized measures of TDLU involution, with high intra/inter pathologist reproducibility in normal breast tissue, predict subsequent breast cancer risk among women in the Mayo benign breast disease (BBD) cohort. We performed a masked evaluation of biopsies from 99 women with BBD who subsequently developed breast cancer (cases) after a median of 16.9 years and 145 age-matched controls. We assessed three metrics inversely related to TDLU involution: TDLU count/mm(2), median TDLU span (microns, which approximates acini content), and median category of acini counts/TDLU (0-10; 11-20; 21-30; 31-50; >50). Associations with subsequent breast cancer risk for quartiles (or categories of acini counts) of each of these measures were assessed with multivariable conditional logistic regression to estimate odds ratios (ORs) and 95 % confidence intervals (CI). In multivariable models, women in the highest quartile compared to the lowest quartiles of TDLU counts and TDLU span measures were significantly associated with subsequent breast cancer diagnoses; TDLU counts quartile4 versus quartile1, OR = 2.44, 95 %CI 0.96-6.19, p-trend = 0.02; and TDLU spans, quartile4 versus quartile1, OR = 2.83, 95 %CI = 1.13-7.06, p-trend = 0.03. Significant associations with categorical measures of acini counts/TDLU were also observed: compared to women with median category of <10 acini/TDLU, women with >25 acini counts/TDLU were at significantly higher risk, OR = 3.40, 95 %CI 1.03-11.17, p-trend = 0.032. Women with TDLU spans and TDLU count measures above the median were at further increased risk, OR = 3.75 (95 %CI 1.40-10.00, p-trend = 0.008), compared with women below the median for both of these metrics. Similar results were observed for combinatorial metrics of TDLU acini counts/TDLU, and TDLU count. Standardized quantitative measures of TDLU counts and acini counts approximated by TDLU span measures or visually assessed in categories are independently associated with breast cancer risk. Visual assessment of TDLU numbers and acini content, which are highly reproducible between pathologists, could help identify women at high risk for subsequent breast cancer among the million women diagnosed annually with BBD in the US.

Entities:  

Keywords:  Breast cancer risk; Lobular involution

Mesh:

Year:  2016        PMID: 27488681      PMCID: PMC5045857          DOI: 10.1007/s10549-016-3908-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  33 in total

1.  Quantitative Analysis of TDLUs using Adaptive Morphological Shape Techniques.

Authors:  Adrian Rosebrock; Jesus J Caban; Jonine Figueroa; Gretchen Gierach; Laura Linville; Stephen Hewitt; Mark Sherman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-29

2.  Age-related lobular involution and risk of breast cancer.

Authors:  Tia R Milanese; Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; Amy C Degnim; Celine M Vachon; Carol A Reynolds; Romayne A Thompson; L Joseph Melton; Ellen L Goode; Daniel W Visscher
Journal:  J Natl Cancer Inst       Date:  2006-11-15       Impact factor: 13.506

3.  Involution and the etiology of breast cancer.

Authors:  D E Henson; R E Tarone
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

4.  Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.

Authors:  Kimberly H Allison; Linn A Abraham; Donald L Weaver; Anna N A Tosteson; Heidi D Nelson; Tracy Onega; Berta M Geller; Karla Kerlikowske; Patricia A Carney; Laura E Ichikawa; Diana S M Buist; Joann G Elmore
Journal:  Cancer       Date:  2015-01-20       Impact factor: 6.860

5.  Independent association of lobular involution and mammographic breast density with breast cancer risk.

Authors:  Karthik Ghosh; Celine M Vachon; V Shane Pankratz; Robert A Vierkant; Stephanie S Anderson; Kathleen R Brandt; Daniel W Visscher; Carol Reynolds; Marlene H Frost; Lynn C Hartmann
Journal:  J Natl Cancer Inst       Date:  2010-10-29       Impact factor: 13.506

6.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

7.  Novel breast tissue feature strongly associated with risk of breast cancer.

Authors:  Kevin P McKian; Carol A Reynolds; Daniel W Visscher; Aziza Nassar; Derek C Radisky; Robert A Vierkant; Amy C Degnim; Judy C Boughey; Karthik Ghosh; Stephanie S Anderson; Douglas Minot; Jill L Caudill; Celine M Vachon; Marlene H Frost; V Shane Pankratz; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

8.  Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.

Authors:  Xiaohong R Yang; Jonine D Figueroa; Roni T Falk; Hong Zhang; Ruth M Pfeiffer; Stephen M Hewitt; Jolanta Lissowska; Beata Peplonska; Louise Brinton; Montserrat Garcia-Closas; Mark E Sherman
Journal:  Breast Cancer Res       Date:  2012-04-18       Impact factor: 6.466

9.  Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Authors:  Hisani N Horne; Mark E Sherman; Ruth M Pfeiffer; Jonine D Figueroa; Zeina G Khodr; Roni T Falk; Michael Pollak; Deesha A Patel; Maya M Palakal; Laura Linville; Daphne Papathomas; Berta Geller; Pamela M Vacek; Donald L Weaver; Rachael Chicoine; John Shepherd; Amir Pasha Mahmoudzadeh; Jeff Wang; Bo Fan; Serghei Malkov; Sally Herschorn; Stephen M Hewitt; Louise A Brinton; Gretchen L Gierach
Journal:  Breast Cancer Res       Date:  2016-02-18       Impact factor: 6.466

10.  Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status.

Authors:  Melissa Rotunno; Xuezheng Sun; Jonine Figueroa; Mark E Sherman; Montserrat Garcia-Closas; Paul Meltzer; Tyisha Williams; Sallie Smith Schneider; D Joseph Jerry; Xiaohong R Yang; Melissa A Troester
Journal:  Breast Cancer Res       Date:  2014-07-08       Impact factor: 6.466

View more
  30 in total

1.  The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients.

Authors:  Hyuna Sung; Changyuan Guo; Erni Li; Jing Li; Ruth M Pfeiffer; Jennifer L Guida; Renata Cora; Nan Hu; Joseph Deng; Jonine D Figueroa; Mark E Sherman; Gretchen L Gierach; Ning Lu; Xiaohong R Yang
Journal:  Int J Cancer       Date:  2019-01-07       Impact factor: 7.396

2.  Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Maeve Mullooly; Samantha Puvanesarajah; Mark E Sherman; Melissa A Troester; Gretchen L Gierach; Shaoqi Fan; Ruth M Pfeiffer; Linnea T Olsson; Manila Hada; Erin L Kirk; Pamela M Vacek; Donald L Weaver; John Shepherd; Amir Mahmoudzadeh; Jeff Wang; Serghei Malkov; Jason M Johnson; Stephen M Hewitt; Sally D Herschorn
Journal:  Cancer Prev Res (Phila)       Date:  2019-10-23

Review 3.  Progesterone and Breast Cancer.

Authors:  Britton Trabert; Mark E Sherman; Nagarajan Kannan; Frank Z Stanczyk
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

4.  Serum hormone levels and normal breast histology among premenopausal women.

Authors:  Mark E Sherman; Thomas de Bel; Michael G Heckman; Launia J White; Joshua Ogony; Melody Stallings-Mann; Tracy Hilton; Amy C Degnim; Robert A Vierkant; Tanya Hoskin; Matthew R Jensen; Laura Pacheco-Spann; Jill E Henry; Anna Maria Storniolo; Jodi M Carter; Stacey J Winham; Derek C Radisky; Jeroen van der Laak
Journal:  Breast Cancer Res Treat       Date:  2022-05-03       Impact factor: 4.624

5.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

6.  Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue.

Authors:  Hannah Oh; Clara Bodelon; Maya Palakal; Nilanjan Chatterjee; Mark E Sherman; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Susan E Clare; Daniel W Visscher; Carolyn Mies; Stephen M Hewitt; Louise A Brinton; Anna Maria V Storniolo; Chunyan He; Montserrat Garcia-Closas; Stephen J Chanock; Gretchen L Gierach; Jonine D Figueroa
Journal:  Breast Cancer Res Treat       Date:  2016-06-24       Impact factor: 4.872

7.  Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

Authors:  Hannah Oh; Ruth M Pfeiffer; Roni T Falk; Hisani N Horne; Jackie Xiang; Michael Pollak; Louise A Brinton; Anna Maria V Storniolo; Mark E Sherman; Gretchen L Gierach; Jonine D Figueroa
Journal:  Int J Cancer       Date:  2018-04-01       Impact factor: 7.396

8.  Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.

Authors:  Mustapha Abubakar; Shaoqi Fan; Erin Aiello Bowles; Lea Widemann; Máire A Duggan; Ruth M Pfeiffer; Roni T Falk; Scott Lawrence; Kathryn Richert-Boe; Andrew G Glass; Teresa M Kimes; Jonine D Figueroa; Thomas E Rohan; Gretchen L Gierach
Journal:  JNCI Cancer Spectr       Date:  2021-02-06

9.  TDLU Involution and Breast Cancer Risk-Reply.

Authors:  Yujing J Heng; Kevin H Kensler; Gabrielle M Baker; Laura C Collins; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04       Impact factor: 4.090

10.  Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk.

Authors:  Rulla M Tamimi; Yujing J Heng; Kevin H Kensler; Emily Z F Liu; Suzanne C Wetstein; Allison M Onken; Christina I Luffman; Gabrielle M Baker; Laura C Collins; Stuart J Schnitt; Vanessa C Bret-Mounet; Mitko Veta; Josien P W Pluim; Ying Liu; Graham A Colditz; A Heather Eliassen; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.